BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24461764)

  • 1. Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?
    Saracino A; Bruno G; Scudeller L; Punzi G; Lagioia A; Ladisa N; Monno L; Angarano G
    J Clin Virol; 2014 Mar; 59(3):167-71. PubMed ID: 24461764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
    Saracino A; Cozzi-Lepri A; Shanyinde M; Ceccherini Silberstein F; Nozza S; Di Biagio A; Cassola G; Bruno G; Capobianchi M; Puoti M; Monno L; d'Arminio Monforte A;
    PLoS One; 2018; 13(1):e0190302. PubMed ID: 29324755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.
    Abravanel F; Raymond S; Pambrun E; Winnock M; Bonnard P; Sogni P; Trimoulet P; Dabis F; Salmon-Ceron D; Izopet J;
    PLoS One; 2012; 7(11):e50289. PubMed ID: 23226258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection.
    Basso M; Zago D; Scaggiante R; Cavinato S; Pozzetto I; Stagni C; Parisatto B; Cattelan AM; Battagin G; Sarmati L; Parisi SG
    Sci Rep; 2021 Apr; 11(1):9274. PubMed ID: 33927306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process.
    Saracino A; Monno L; Scudeller L; Bruno G; Ladisa N; Punzi G; Volpe A; Lagioia A; Angarano G
    BMC Infect Dis; 2013 May; 13():220. PubMed ID: 23678991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
    PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
    Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
    BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR.
    Saracino A; Bruno G; Scudeller L; Ladisa N; de Gennaro N; Allegrini M; Monno L; Angarano G
    J Clin Virol; 2016 Aug; 81():94-9. PubMed ID: 27371888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
    Ferrer P; Tello M; Montecinos L; Tordecilla R; Rodríguez C; Beltrán C; Guzmán MA; Ferrés M; Pérez CM; Afani A
    J Clin Virol; 2014 Jul; 60(3):290-4. PubMed ID: 24793966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
    Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
    Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
    Soulié C; Charpentier C; Flandre P; Nino C; Carcelain G; Simon A; Katlama C; Landman R; Brun-Vézinet F; Descamps D; Calvez V; Marcelin AG
    J Med Virol; 2012 Dec; 84(12):1853-6. PubMed ID: 23080487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
    Abad-Fernández M; Moreno A; Dronda F; del Campo S; Quereda C; Casado JL; Pérez-Elías MJ; Moreno S; Vallejo A
    AIDS; 2015 Feb; 29(4):401-9. PubMed ID: 25565497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study.
    Zhou K; Hu F; Wang C; Xu M; Lan Y; Morano JP; Lemon SM; Tucker JD; Cai W
    BMC Infect Dis; 2015 Sep; 15():401. PubMed ID: 26424404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
    de Mendoza C; Rodriguez C; García F; Eiros JM; Ruíz L; Caballero E; Aguilera A; Leiva P; Colomina J; Gutierrez F; del Romero J; Aguero J; Soriano V;
    J Antimicrob Chemother; 2007 Apr; 59(4):698-704. PubMed ID: 17327295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of chemokine receptor gene variants with HIV-1 genotype predicted tropism.
    Parczewski M; Urbańska A; Maciejewska K; Clark J; Leszczyszyn-Pynka M
    HIV Med; 2014 Nov; 15(10):577-86. PubMed ID: 24750723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
    Verhofstede C; Brudney D; Reynaerts J; Vaira D; Fransen K; De Bel A; Seguin-Devaux C; De Wit S; Vandekerckhove L; Geretti AM
    HIV Med; 2011 Oct; 12(9):544-52. PubMed ID: 21518222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.
    Treviño A; Soriano V; Poveda E; Parra P; Cabezas T; Caballero E; Roc L; Rodríguez C; Eiros JM; Lopez M; De Mendoza C;
    J Antimicrob Chemother; 2014 Aug; 69(8):2191-4. PubMed ID: 24788659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.